Find Academic Supervisors

• RNA Biology
• Cancer Biology
• Translational Regulation
• +3 more

Stephan Vagner serves as Director of Research Unit Genome Integrity, RNA and Cancer (UMR3348) and Team Leader of RNA Biology, Signalling and Cancer (U1278) at Institut Curie in Orsay, while holding a professorship at Ecole Polytechnique since 2018. His leadership roles include Site Coordinator of the Research Center and Director of CNRS UMR3348/INSERM U1278 since 2020. Dr. Vagner's research focuses on RNA regulations and RNA-binding proteins in cancer biology, with three primary axes: (1) DNA damage response mechanisms including intronic polyadenylation, (2) Tumor-intrinsic resistance to targeted therapies through mRNA translation reprogramming, and (3) Tumor cell-environment crosstalk in melanoma and leukemia. His work employs biochemical analyses, genome-wide RNA studies, and in vivo tumor models across cutaneous melanoma, breast cancer, and acute T lymphoblastic leukemia. Analysis of his publication history reveals sustained expertise in translational regulation during therapy resistance, with recent emphasis on unconventional RNA-binding activities of metabolic enzymes and genotoxic stress responses. His collaborative network spans Institut Curie, CNRS, Inserm, and Ecole Polytechnique. As Team Leader, he mentors researchers across multiple projects investigating RNA-protein interactions in cancer progression. His laboratory utilizes advanced techniques including RNA-seq, 3'seq, polysome profiling, and iCLIP for RNA-protein interaction studies. The RNA Biology, Signalling and Cancer team operates within the Genome Integrity, RNA and Cancer unit, focusing on co-/post-transcriptional gene regulation in therapeutic contexts through biochemical, genomic, and phenotypic analyses.

Marcin TabakaView profile

Researcher

• Computational Genomics
• Single-Cell Genomics
• Cell Reprogramming
• +3 more

Marcin Tabaka, PhD is a Group Leader at the International Centre for Translational Eye Research (ICTER), which is part of the Institute of Physical Chemistry, Polish Academy of Sciences in Warsaw, Poland. He leads the Computational Genomics Group focused on applying high-throughput single-cell genomics technologies to diverse research areas including eye research, cell reprogramming, immunology, and cancer. Dr. Tabaka graduated from the Jagiellonian University Faculty of Chemistry in 2004 and obtained his PhD at the Institute of Physical Chemistry, Polish Academy of Science (IPC PAS) in 2009. He completed postdoctoral training in Mathematical Biology at IPC PAS (2010-2014) followed by research at the Klarman Cell Observatory headed by Aviv Regev at the Broad Institute of MIT and Harvard (2014-2019). He established his independent research group at ICTER in September 2020. His research focuses on computational approaches to single-cell genomics, with applications in translational eye research and disease mechanisms. His work spans multiple disciplines including: Computational biology and bioinformatics Single-cell and single-nucleus RNA sequencing Developmental biology and cell reprogramming Immunology and cancer biology Retinal degeneration and eye disease mechanisms Dr. Tabaka's research group has developed several computational tools for single-cell data analysis, including the recently published "Ocelli" open-source platform for developmental multimodal single-cell data analysis. His work demonstrates strong interdisciplinary collaboration between computational biology, molecular biology, and clinical research, particularly in the field of ophthalmology. Dr. Tabaka is actively involved in mentoring researchers and collaborating on multiple interdisciplinary projects, though specific students are not listed in the available information. His research is supported by institutional funding from ICTER and likely external grants related to his publications in high-impact journals. He leads the Computational Genomics Group at ICTER, which maintains strong collaborations with international research institutions including the Broad Institute of MIT and Harvard. The group combines computational expertise with experimental approaches to address fundamental questions in genomics and translational medicine, particularly in the context of eye diseases.

• Oncology
• Dentistry
• Genetics
• +3 more

Marta Barzał-Nowosielska is an Adjunct Professor at the Department of Restorative Dentistry within the Faculty of Medicine with the Division of Dentistry and Division of Medical Education at the Medical University of Bialystok. Her research focuses on the intersection of virology, oncology, and dentistry, particularly examining human papillomavirus (HPV) in relation to oral pathology and cancer development. Specializes in HPV infection mechanisms and their role in oral neoplasms Expertise in molecular diagnostics and immunohistochemical analysis Active in interdisciplinary medical education initiatives With 8 documented publications and a Scopus h-index of 2, her work emphasizes tumor suppressor pathways, genetic susceptibility, and environmental risk factors in oral oncology. Her research utilizes polymerase chain reaction techniques and explores metabolic reprogramming in HPV-associated tumors. Current research trends include: HPV genotyping and viral integration analysis Development of diagnostic protocols for oral lesions Regional epidemiological studies in Polish populations Academic productivity metrics (SNIP: 2.674)

Iwona CiereszkoView profile

Professor

• Plant Physiology
• Ecophysiology
• Environmental Stress Responses
• +4 more

Iwona Ciereszko is a Professor at the University of Białystok, affiliated with the Department of Plant Biology and Ecology within the Faculty of Biology. She holds significant administrative roles, including Head of the Plant Physiology Laboratory (since 2019), former Head of the Department of Plant Physiology (2006–2019), and Dean of the Faculty of Biology and Chemistry (2012–2016). Her research focuses on plant responses to environmental stresses, particularly phosphate deficiency, oxidative stress, and pathogen interactions. Key interests include ecophysiology, photosynthetic regulation, and signal transduction pathways in plants. Education and Career: Extensive academic career spanning over three decades, with leadership in botanical research and university administration. Memberships: Active in Polish and international societies, including the Polish Society of Experimental Plant Biology (PTBER) and the Polish Botanical Society (PTB). Served as PTBER President (2015–2017) and Chair of the Plant Physiology and Biochemistry Section at PTB (2010–2013). Her research emphasizes plant acclimation to stress, including nutrient deficiencies, pathogen attacks, and mechanical injuries. Notable contributions include studies on sucrose metabolism, acid phosphatase activity under phosphate starvation, and mitochondrial roles in seed aging. She has supervised over 70 master’s and 20 bachelor’s theses, and guided three doctoral students to completion. Publications span over 100 peer-reviewed articles, focusing on plant stress physiology and molecular mechanisms. Recent work includes investigations into jasmonic acid-mediated defense against fungi and the bioherbicidal potential of essential oils. Professional service includes roles in academic committees, journal evaluations, and organizing international conferences, such as the 8th PTBER Conference (2017).

• Molecular Biology
• Pharmacology
• Biochemistry
• +4 more

Sylwia Bartoszewska serves as an Assistant Professor in the Department of Inorganic Chemistry at the Faculty of Pharmacy, Medical University of Gdańsk, holding a habilitation degree (Dr. Habil.) earned after obtaining her doctorate in 2016. Her interdisciplinary work bridges pharmacology (75% focus) and medical sciences (25%) through molecular investigations of cellular stress mechanisms. Research Focus Dr. Bartoszewska's laboratory specializes in microRNA-mediated regulation of the unfolded protein response (UPR) and hypoxia signaling pathways, with particular emphasis on miR-1244, miR-301a, and miR-429 in cancer progression. Her team explores how HIF isoform switching (HIF-1 to HIF-2) governs tumor microenvironment adaptation and investigates cationic lipopeptides as novel antimicrobial agents targeting bacterial membranes. This dual focus on stress-response molecular biology and peptide-based therapeutics defines her innovative research trajectory. Publication Trends Analysis of her 15 most recent publications (2021-2024) reveals three converging research streams: (1) UPR-miRNA crosstalk in cell fate decisions, (2) HIF dynamics in hypoxic tumors, and (3) structure-activity relationships of antimicrobial lipopeptides. Her work consistently connects fundamental molecular mechanisms to translational applications, particularly in cancer diagnostics and next-generation antibiotics. Collaborative Framework Active member of PRA 3: Research Team X at MUG studying civilization disease mechanisms Integrates biochemical, molecular, and cellular approaches across pharmacology and medical science domains Maintains 54 publications with significant bibliometric impact (MEiN Score: 3,294)